Better Screening for Prostate Cancer
Prostate Cancer is the second deadliest cancer for American men, it will kill a projected 29,430 in 2018. Simultaneously, it is overdiagnosed and overtreated in men with indolent prostate cancer. This leads to unnecessary treatments such as prostatectomy and radiation therapy.
PSA: An Imperfect Screening Tool
Prostate Specific Antigen or PSA is currently the standard test used for prostate cancer screening. However, it has several shortcomings, including: